Legislation allowing ADHD med refills for more than a month at a time gains speed at State House
Democratic lawmakers Sen. Alana DiMario of Narragansett and Rep. Michelle McGaw of Portsmouth are sponsoring not-quite-identical bills that would increase how much ADHD medication patients can receive at once. (Photo by Alexander Castro/Rhode Island Current)
Availability of tightly regulated ADHD medications could improve under a pair of bills that continue to move through the Rhode Island General Assembly following a Senate floor vote Tuesday night.
Bill S795 by Sen. Alana DiMario, a Narragansett Democrat, passed 36-0 and now joins the amended version of bill H5866 by Portsmouth Democratic Rep. Michelle McGaw, which passed the House 70-0 on April 22. Now each bill awaits a committee hearing in the opposite chamber. Both bills would allow for non-opioid Schedule II stimulants like Adderall, Ritalin, and Vyvanse, which are commonly used as ADHD treatments, to be prescribed and dispensed in larger amounts for doctor and patient convenience.
Sen. Pam Lauria, a Barrington Democrat and nurse practitioner, stood to commend DiMario's legislation on the Senate floor, calling it 'an incredibly important bill, particularly as we are talking about the administrative burdens on primary care providers.'
'These are chronic medications that these people take every day, but every month, because of the very real safeguards for these medications, the extra time that it takes for primary care providers or psychiatrists… to do this work is cumbersome,' Lauria said.
The 'cumbersome' refill schedule is exactly what DiMario's legislation wants to fix. Under current federal rules, providers can write three separate 30-day prescriptions for a total 90-day supply. Some states have adopted revised rules that allow patients to pick up all 90 days' worth at once, as Massachusetts did in 2024.
In the Ocean State, however, patients still have to return to the pharmacy monthly and pick up the prescriptions one by one. Patients also have to contact their doctor to send in the second and third month's prescriptions, piling onto providers' workloads.
Alas, there's one important difference between the bills: DiMario's version allows for patients to fill all 90 days at once, while McGaw's amended version caps fills at 60 days.
DiMario said in a phone interview Wednesday that she believes the House and Senate will eventually agree on a version of the legislation as the state's legislative session winds down in the following weeks.
'We really believe that 90 days provides the most meaningful kind of time burden relief for patients and providers,' DiMario said. 'My position is that I'm strongly advocating for the 90 days, but I do believe that an agreement will be reached.'
Greg Paré, a Senate spokesperson, did not immediately have scheduling details for the bills Wednesday, and noted that the bills' different time frames 'will have to be addressed.'
McGaw agreed in a phone call Wednesday evening, saying that with the Senate's OK of a 90-day supply, the legislation is 'still sort of in limbo' until she can meet with the House committee chair and the senate's policy team.
McGaw originally proposed a 90-day supply but reduced it to 60 days after feedback from some prescribers. She thinks a single version of the bill will eventually emerge after more conversations, acknowledging that edits to not-quite-identical legislation in both chambers is not uncommon as the legislative session nears its end.
'I would be happy with either version, whether we decide on 60 or 90 days,' McGaw said. 'In either case, it helps to reduce some of the administrative burdens for our physicians, and also helps parents or patients for whom it's a challenge to go to the doctor every month and get a new prescription.'
On the Senate floor, DiMario said the bill builds on successful legislation last year that authorized electronic transfers of ADHD prescriptions, pending state adoption of new federal standards.
Both last year's and this year's ADHD drug bills are designed to alleviate headaches for patients and providers alike amid pill shortages ongoing since 2022, attributed to a number of factors, including a sharp increase in adult diagnoses. The Drug Enforcement Administration previously faced scrutiny for limiting production quotas of Schedule II drugs, but it increased some of those quotas in 2024.
An October 2024 edition of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report relayed that there were an estimated 15.5 million U.S. adults with an ADHD diagnosis in 2023; about half were diagnosed as adults. Roughly one-third of these adults take stimulant drugs for their condition, and shortages affected 71.5% of this population's access to their medications.
A 2025 article in the American Journal of Managed Care noted that stimulant prescriptions have almost doubled in the past 10 years.
'There is only so much pharmaceutical companies can do when demand severely outweighs supply,' the authors wrote.
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Nearly 100 House Democrats urge RFK Jr. to restore millions in family planning grants
Nearly 100 House Democrats are calling on Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to restore tens of millions of dollars in federal family planning grants to more than a dozen organizations that have been frozen for more than two months. In a letter to Kennedy sent Friday and seen first by The Hill, 95 lawmakers said the organizations that had their Title X funding frozen on March 31 — including nine Planned Parenthood clinics — are still in the dark about the status of their grants. At the time, the clinics said they received letters from the administration saying the grants were being 'temporarily withheld' due to possible civil right violations and President Trump's executive orders prohibiting the promotion of diversity, equity and inclusion (DEI) and 'taxpayer subsidization of open borders.' More than two months later, the lawmakers said the grantees 'remain without funding and have received no communication from the administration regarding the status of the investigations, the expected timeline, or the future of their funding.' HHS declined to comment, citing ongoing litigation. The agency is being sued over the freeze by the National Family Planning and Reproductive Health Association (NFPRHA) and the American Civil Liberties Union (ACLU). 'Congress has already appropriated these funds, and the administration has a responsibility to distribute them without undue delay or obstruction, ensuring that critical care is not disrupted for millions of people who rely on Title X services,' the group of lawmakers wrote. The letter was led by Reps. Josh Gottheimer (D-N.J.), Judy Chu (D-Calif.), Lizzie Fletcher (D-Texas) and Sharice Davids (D-Kan.) and signed by 91 other Democrats. Title X is the country's only federal program dedicated to providing affordable birth control and other sexual and reproductive health care to low-income Americans and has done so since the 1970s. The lawmakers timed the letter to coincide with the 60th anniversary of the U.S. Supreme Court's ruling in Griswold v. Connecticut, which established a constitutional right to privacy regarding contraception and reproductive decisions. 'However, due to the actions of this administration, reproductive freedom is under threat,' the lawmakers wrote. The first Trump administration prohibited providers from receiving Title X funding if they mentioned abortion or referred patients for abortions. It also required clinics to construct separate facilities for the procedure and other services. More than a dozen grantees, including all Planned Parenthood affiliates nationwide, left the program in protest because of the rule. The Biden administration reversed Trump's Title X rule in 2021. Updated at 3:26 p.m. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Republicans are also sweating Medicaid cuts in Big Beautiful Bill, poll finds
More than four in 10 Republicans are worried about the Medicaid cuts being contemplated as a part of President Donald Trump's domestic policy mega-bill, a reminder that key parts of President Donald Trump's base also stand to be adversely impacted by the sprawling legislation. One-third of respondents to the new KFF poll identify as MAGA Republicans, reflecting the overall enrollment in the joint state/federal health care program. Among enrollees, more than a quarter are Republican, including 1 in 5 who identify as MAGA Republicans, according to the pollWhil. Republicans who control the U.S. Senate now have the bill, which passed the U.S. House by a single vote late last month. The upper chamber is contemplating its own changes to the legislation, which would blow up the deficit and impose sweeping social service cuts as it seeks to make Trump's first-term tax cuts permanent. The poll found that a large majority of rural Americans and those with lower household incomes, another key part of Trump's base, are worried that Medicaid reductions would lead to more children and adults losing coverage. They said they also feared it would harm health care providers in their communities and make it more difficult for them and their families to access care, according to the poll. Those findings broke down along partisan lines. Nonetheless, half of rural Republicans said they were worried about people becoming uninsured, according to the poll. Rural health care providers, who often rely on Medicaid funding, may be "especially vulnerable to the decreased federal spending included in the reconciliation bill," according to KFF pollsters. Public views on how the Republican White House's policies will impact the nation's health care system are largely partisan. But overall, most of the public says the administration's policies will weaken Medicaid and Medicare, including most Democrats and independents. Republicans said they expect those policies to strengthen or have no impact on these programs. Read More: A 'historic battle': Mass pols protest Medicaid cuts in 'Big Beautiful Bill' | John L. Micek Among Republican Medicaid enrollees, however, 'views are mixed with similar shares saying the policies will strengthen, weaken, or have no impact on the program they rely on,' according to the poll. In Massachusetts, Democratic Gov. Maura Healey and her allies in the state Legislature have predicted grim consequences for MassHealth, as Medicaid is known in the Bay State. As it's currently written, the bill that passed the U.S. House by a single vote last week would reduce Medicaid spending by nearly $700 billion over a decade, according to an analysis by the Congressional Budget Office. That would cost the state's health care system $1.75 billion, affecting 250,000 people statewide, MassLive previously reported. This is my classroom. ICE isn't welcome here. What a monk, a librarian and a dentist have to do with Harvard's fight with Trump Harvard relinquishes possession of slave photos after years-long dispute Trump says Musk has 'lost his mind' as he disses peace offering Judge blocks Trump admin from banning Harvard international students from entering US Read the original article on MassLive.
Yahoo
3 hours ago
- Yahoo
B.C. mom picks up her son's ADHD medication, is given an opioid instead
A mother on Vancouver Island is warning people to double check their prescriptions after she was accidentally dispensed the powerful opioid hydromorphone instead of her son's regular ADHD medication. Comox, B.C., resident Sarah Paquin, 31, says she still shudders to think about what could have happened to her nine-year-old son had her husband not noticed the medication looked different before he gave it to him. "It was terrifying," Paquin said, standing in her front yard and playing with one of her three boys. "One simple little mistake like that could have ended horribly." WATCH | 9-year-old dispensed opioid in pharmacy mix-up: Paquin says she didn't think too much of it when she went to pick up her son Declan's medication last week and the staff member at her local Shoppers Drug Mart pharmacy didn't check her ID or take out the prescription from the bag. The next day, her husband was about to give Declan his medication when he saw the pills were a different colour and shape than normal. Her husband looked at the bottle and noticed the prescription was for someone else, and that it was for hydromorphone. Right away he returned the pills to the pharmacy. "Immediately your mind goes to the worst case scenario," Paquin said. "The results could have been catastrophic and it just makes my heart sink to think about what could have happened." Hydromorphone is a powerful opioid that is two to eight times stronger than morphine and is often used to treat acute pain or chronic cancer pain. According to the Mayo Clinic, it can cause serious unwanted effects or fatal overdose in children. Human error CBC News reached out to Loblaws, the company that owns Shoppers Drug Mart. In a written statement, the company said the incident was a case of "human error" that never should have happened. "We have controls in place to minimize risks like this — where the patient was handed the wrong prescription bag — and the associate will review these with employees to avoid a similar situation in the future," the company said. Paquin says she has since heard from the pharmacist, who was very apologetic. She says he acknowledged that steps were missed and standards were dropped, and told her the employee who dispensed the medication has been suspended pending an internal investigation. Asking for accountability Despite his reassurances, Paquin has filed a complaint with the College of Pharmacists of B.C. "The pharmacy needs to take responsibility, be held accountable for what happened," she said. In an email, the college told CBC News it takes these types of errors very seriously. "We have legal requirements in the Health Professions Act bylaws in place to prevent these occurrences, including mandatory standards for prescription preparation to ensure accuracy of the prescription product and consultations for all prescriptions, to make sure clients understand their medication, how to take it properly, and address any questions," the college said. As part of pharmacists' consultation with clients, they are required to confirm the person's identity, name and the strength and purpose of the drug, it added. In 2023-24, the college says it received a total of 990 concerns through its intake process. Of those, 54 became formal complaints and investigations, 16 of which were medication related. Paquin decided to share her ordeal on social media, to warn others to check their prescription before taking it. "It's scary that it happened to us, but I'm also in a way kind of thankful that it happened to us and we caught it because it could have been given to somebody who didn't notice and got hurt," she said.
